ATHE

Alterity Therapeutics Limited ATHE

ATHE
Alterity Therapeutics Limited DYAI
Dyadic International, Inc. EVAX
Evaxion Biotech A/S NNVC
NanoViricides, Inc. LIMN
Liminatus Pharma, Inc. Class A Common Stock MURA
Mural Oncology plc IGC
IGC Pharma, Inc. BTAI
BioXcel Therapeutics, Inc. ANVS
Annovis Bio, Inc. MAIA
MAIA Biotechnology, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ATHE DYAI EVAX NNVC LIMN MURA IGC BTAI ANVS MAIA
6M -30.58 % 1.80 % 120.27 % -10.53 % -96.58 % -21.84 % -4.36 % 8.67 % 46.57 % -25.00 %
YTD -9.92 % -42.53 % 43.51 % -4.23 % -82.26 % -36.25 % -15.88 % -66.03 % -12.23 % -35.41 %
1Y 35.48 % -39.39 % 0.45 % -8.72 % -82.26 % -48.87 % -17.50 % -72.05 % -21.73 % -37.21 %
3Y -4.00 % -21.26 % -93.02 % -6.53 % -82.26 % -46.32 % -25.59 % -99.22 % -61.24 % -61.43 %
5Y -76.50 % -83.31 % -98.66 % -61.69 % -82.26 % -46.32 % -82.64 % -99.69 % -22.79 % -69.73 %
10Y -92.73 % -40.12 % -98.66 % -93.52 % -82.26 % -46.32 % 31.71 % -98.79 % -53.23 % -69.73 %
From the beginning -99.50 % 25.00 % -98.66 % -96.11 % -82.26 % -46.32 % -99.45 % -98.79 % -53.23 % -69.73 %

Dividend